Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Thousands of duloxetine bottles, an antidepressant sold
FDA recalls more than 7,000 bottles of antidepressant over a possible cancerous chemical
The FDA is recalling more than 7,000 bottles of the antidepressant duloxetine due to a possible cancer-causing chemical.
This antidepressant is being recalled: Here’s why
The U.S. Food and Drug Administration (FDA) has issued a nationwide recall of thousands of bottles of antidepressants. These bottles were found to contain levels of a potentially cancer-causing chemical.
Thousands of duloxetine bottles, an antidepressant sold as Cymbalta, recalled over toxic chemical
Some bottles of the antidepressant duloxetine, sold under the brand name Cymbalta, were recalled due to the presence of a toxic chemical.
7,100 bottles of antidepressant recalled by FDA now in 2nd highest risk class
Duloxetine Delayed-Release Capsules were recalled because the pills may contain high levels of a cancer-causing chemical.
Antidepressant recall: FDA upgrades medication risk class to 2nd highest level in recall update
The U.S. Food and Drug Administration is urging patients not to stop taking their prescribed medication if it falls under the recall but instead to address any concerns and other potential treatment o
Antidepressant recalled: 2nd-highest FDA risk level; drug contains cancerous chemical
The U.S. Food and Drug Administration updated the risk level of a recalled antidepressant due to the product containing high levels of a cancer-causing chemical.
FDA Has Recalled Thousands of Bottles of Antidepressant Duloxetine, Sold Under Brand Name Cymbalta: Here’s Why
The Duloxetine Delayed-Release Capsules' voluntary recall began on Oct. 10 after the FDA deemed the medication the second-highest risk classification. Over 7,100 bottles of Duloxetine were recalled, including 500 delayed-release 20mg capsules. The lot number is 220128, and the expiration date is 12/2024, per the FDA report.
FDA issues recall for antidepressant drug
The Federal Drug Administration issued a recall on Tuesday for a common medicine for depression. Over 7,000 bottles of Duloxetine were recalled due to the elevated presence of Nitrosamine, an ingredient believed to be cancerous,
Antidepressant recall: FDA upgrades risk level due to cancer-causing chemical
Now, the FDA is assigning the second-highest risk level to the recall of Duloxetine Delayed-Release Capsules, produced by Towa Pharmaceutical Europe, according to agency records and reported by SILive.com sister site NJ.com. Duloxetine is used to treat depression, anxiety and nerve pain caused by fibromyalgia.
FDA Recalls Thousands Of Duloxetine Antidepressant Bottles | Here's Why
The US Food and Drug Administration has recalled thousands of bottles of Duloxetine antidepressant, saying it contained high levels of a cancer-causing chemical. The federal agency has reportedly upgraded the level of risk.
6d
on MSN
When Stock Prices Fall, Antidepressant Prescriptions Rise
A new study finds that is particularly true for people nearing retirement.
6d
Mindfulness may be as effective as antidepressant for anxiety symptoms
Miindfulness-based stress reduction may be as effective as escitalopram (Lexapro — an SSRI commonly used to treat depression ...
1d
What experts say about taking psilocybin as an alternative treatment for depression
Antidepressants, the gold standard treatment for depression, don’t work for many people. Will psilocybin be an alternative?
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Trending now
NK troops in RU confirmed
Linked to E. coli outbreak
Arlington visit records order
Trespassing charge upheld
Veteran film producer dies
Kristy now Category 2
G7 Ukraine loan advances
2 US troops injured in raid
Dodgers legend dies
To close 150 locations
Lake Erie toxic algae study
Giant ‘ghost’ fish spotted
DOJ alleges racial bias
FDA approves RSV vaccine
Gun assault trial delayed
Funds corruption guilty plea
First father-son duo in NBA
US fines American Airlines
Bird flu infects 4 in WA
GA election rules appeal
To appear on Rogan podcast
FAA finalizes safety rules
Brain stimulation study
US semiconductor tax credit
Six indicted for fraud in Ohio
Hospitals' IV fluid shortage
Ordered to hand over assets
Feedback